{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T19:48:50Z","timestamp":1794944930168,"version":"4.9.1"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"Supplement_6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sarcoidosis is a disease with heterogeneous manifestations and outcomes, varying in part on the basis of organ involvement. Specifically, patients with sarcoidosis at risk for poor outcomes include individuals with treatment-resistant pulmonary sarcoidosis, including fibrotic pulmonary disease and pulmonary hypertension, as well as those with cardiac, neurologic, and multiorgan disease. The limited but available data relating to these patients with high-risk sarcoidosis, defined as those patients with presentations requiring medical intervention to avoid progressive disability or premature death, was evaluated as part of the National Heart, Lung, and Blood Institute\u2019s workshop to improve understanding of these disease manifestations. In particular, knowledge gaps that preclude a greater understanding of the pathogenesis and management of these severe sarcoidosis clinical phenotypes were identified in the workshop. Research strategies are proposed to address critical knowledge gaps that would further our understanding of these disease manifestations and enhance the care of these patients.<\/jats:p>","DOI":"10.1513\/annalsats.201707-566ot","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T18:51:09Z","timestamp":1509043869000},"page":"S437-S444","source":"Crossref","is-referenced-by-count":48,"title":["High-Risk Sarcoidosis. Current Concepts and Research Imperatives"],"prefix":"10.1093","volume":"14","author":[{"given":"William H.","family":"Sauer","sequence":"first","affiliation":[{"name":"University of Colorado School of Medicine, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barney J.","family":"Stern","sequence":"additional","affiliation":[{"name":"University of Maryland School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Baughman","sequence":"additional","affiliation":[{"name":"University of Cincinnati School of Medicine, Cincinnati, Ohio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Culver","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Royal","sequence":"additional","affiliation":[{"name":"University of Maryland School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,12,1]]},"reference":[{"key":"2026020403042977500_bib1","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","article-title":"Sarcoidosis-related mortality in the United States from 1988 to 2007","volume":"183","author":"Swigris","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020403042977500_bib2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1378\/chest.14-1120","article-title":"Racial difference in sarcoidosis mortality in the United States","volume":"147","author":"Mirsaeidi","year":"2015","journal-title":"Chest"},{"key":"2026020403042977500_bib3","first-page":"154","article-title":"Predicting respiratory failure in sarcoidosis patients","volume":"14","author":"Baughman","year":"1997","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026020403042977500_bib4","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020403042977500_bib5","first-page":"167","article-title":"Sarcoidosis: a long-term follow up study","volume":"17","author":"Chappell","year":"2000","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026020403042977500_bib6","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.00187410","article-title":"Stage IV sarcoidosis: comparison of survival with the general population and causes of death","volume":"38","author":"Nardi","year":"2011","journal-title":"Eur Respir J"},{"key":"2026020403042977500_bib7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","article-title":"Prognosis of intrathoracic sarcoidosis in England: a review of 136 cases after five years\u2019 observation","volume":"2","author":"Scadding","year":"1961","journal-title":"BMJ"},{"key":"2026020403042977500_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","article-title":"An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study","volume":"2","author":"Walsh","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2026020403042977500_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00330-004-2480-4","article-title":"CT findings in severe thoracic sarcoidosis","volume":"15","author":"Hennebicque","year":"2005","journal-title":"Eur Radiol"},{"key":"2026020403042977500_bib10","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1183\/09031936.00025212","article-title":"Imaging of sarcoidosis of the airways and lung parenchyma and correlation with lung function","volume":"40","author":"Nunes","year":"2012","journal-title":"Eur Respir J"},{"key":"2026020403042977500_bib11","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2214\/ajr.174.6.1741751","article-title":"Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function","volume":"174","author":"Abehsera","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"2026020403042977500_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-2007-970332","article-title":"Pathology of sarcoidosis","volume":"28","author":"Rosen","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"2026020403042977500_bib13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/PAS.0b013e3182785a2d","article-title":"End-stage sarcoid lung disease is distinct from usual interstitial pneumonia","volume":"37","author":"Xu","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"2026020403042977500_bib14","first-page":"S37","article-title":"Pulmonary fibrosis of sarcoidosis: new approaches, old ideas","volume":"29","author":"Moller","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026020403042977500_bib15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1164\/rccm.200509-1518OC","article-title":"A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18","volume":"173","author":"Prasse","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020403042977500_bib16","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1164\/rccm.200912-1855OC","article-title":"Gene set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulmonary sarcoidosis","volume":"181","author":"Lockstone","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020403042977500_bib17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1165\/ajrcmb.24.5.4064","article-title":"Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin","volume":"24","author":"Chen","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026020403042977500_bib18","article-title":"Application of \u2018omics\u2019 and systems biology to sarcoidosis research: NHLBI Workshop to Better Understand Disease Variability and Improve Outcomes in Sarcoidosis","author":"Crouser","journal-title":"Ann Am Thorac Soc"},{"key":"2026020403042977500_bib19","doi-asserted-by":"crossref","first-page":"e44818","DOI":"10.1371\/journal.pone.0044818","article-title":"Peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS One"},{"key":"2026020403042977500_bib20","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1513\/AnnalsATS.201503-172OT","article-title":"Rationale and design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) study: sarcoidosis protocol","volume":"12","author":"Moller","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"2026020403042977500_bib21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1183\/09031936.00175907","article-title":"Clinical predictors of pulmonary hypertension in sarcoidosis","volume":"32","author":"Bourbonnais","year":"2008","journal-title":"Eur Respir J"},{"key":"2026020403042977500_bib22","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1378\/chest.128.3.1483","article-title":"Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension","volume":"128","author":"Sulica","year":"2005","journal-title":"Chest"},{"key":"2026020403042977500_bib23","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1378\/chest.09-2002","article-title":"Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation","volume":"138","author":"Baughman","year":"2010","journal-title":"Chest"},{"key":"2026020403042977500_bib24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1183\/09031936.05.00083404","article-title":"Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics","volume":"25","author":"Shorr","year":"2005","journal-title":"Eur Respir J"},{"key":"2026020403042977500_bib25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ccm.2015.08.011","article-title":"Pulmonary hypertension in sarcoidosis","volume":"36","author":"Baughman","year":"2015","journal-title":"Clin Chest Med"},{"key":"2026020403042977500_bib26","first-page":"121","article-title":"Right heart impairment in sarcoidosis: haemodynamic and echocardiographic study","volume":"64","author":"Rizzato","year":"1983","journal-title":"Eur J Respir Dis"},{"key":"2026020403042977500_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005382-199910000-00007","article-title":"A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter","volume":"14","author":"Ng","year":"1999","journal-title":"J Thorac Imaging"},{"key":"2026020403042977500_bib28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1183\/16000617.0058-2015","article-title":"Imaging the heart in pulmonary hypertension: an update","volume":"24","author":"Gr\u00fcnig","year":"2015","journal-title":"Eur Respir Rev"},{"key":"2026020403042977500_bib29","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1378\/chest.14-2546","article-title":"Prostacyclin and oral vasodilator therapy in sarcoidosis-associated pulmonary hypertension: a retrospective case series","volume":"148","author":"Bonham","year":"2015","journal-title":"Chest"},{"key":"2026020403042977500_bib30","first-page":"82","article-title":"Treatment of sarcoidosis-associated pulmonary hypertension: a single centre retrospective experience using targeted therapies","volume":"31","author":"Keir","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026020403042977500_bib31","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1378\/chest.08-1881","article-title":"Treatment of sarcoidosis-associated pulmonary hypertension: a two-center experience","volume":"135","author":"Barnett","year":"2009","journal-title":"Chest"},{"key":"2026020403042977500_bib32","first-page":"139","article-title":"Ambrisentan for sarcoidosis associated pulmonary hypertension","volume":"28","author":"Judson","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026020403042977500_bib33","first-page":"110","article-title":"Inhaled iloprost for sarcoidosis associated pulmonary hypertension","volume":"26","author":"Baughman","year":"2009","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026020403042977500_bib34","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1378\/chest.13-1766","article-title":"Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial","volume":"145","author":"Baughman","year":"2014","journal-title":"Chest"},{"key":"2026020403042977500_bib35","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"2026020403042977500_bib36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2967\/jnumed.112.115121","article-title":"Advanced imaging of cardiac sarcoidosis","volume":"55","author":"Schatka","year":"2014","journal-title":"J Nucl Med"},{"key":"2026020403042977500_bib37","first-page":"19","article-title":"The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026020403042977500_bib38","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"2026020403042977500_bib39","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","article-title":"Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11)","volume":"63","author":"Roberts","year":"1977","journal-title":"Am J Med"},{"key":"2026020403042977500_bib40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijcard.2016.10.101","article-title":"Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis","volume":"227","author":"Padala","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026020403042977500_bib41","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"key":"2026020403042977500_bib42","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"2026020403042977500_bib43","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","article-title":"ACC\/AHA\/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (writing committee to revise the ACC\/AHA\/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons","volume":"51","author":"Epstein","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026020403042977500_bib44","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1540-8167.2012.02350.x","article-title":"Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis","volume":"23","author":"Schuller","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026020403042977500_bib45","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/eus316","article-title":"Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"15","author":"Kron","year":"2013","journal-title":"Europace"},{"key":"2026020403042977500_bib46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/jce.12302","article-title":"Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator","volume":"25","author":"Mohsen","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026020403042977500_bib47","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.hrthm.2012.02.010","article-title":"Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators","volume":"9","author":"Betensky","year":"2012","journal-title":"Heart Rhythm"},{"key":"2026020403042977500_bib48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00019052-200006000-00016","article-title":"Neurosarcoidosis","volume":"13","author":"Zajicek","year":"2000","journal-title":"Curr Opin Neurol"},{"key":"2026020403042977500_bib49","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/NRL.0b013e31819bcf84","article-title":"Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis","volume":"15","author":"Khoury","year":"2009","journal-title":"Neurologist"},{"key":"2026020403042977500_bib50","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s00415-010-5623-3","article-title":"Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis","volume":"257","author":"Petereit","year":"2010","journal-title":"J Neurol"},{"key":"2026020403042977500_bib51","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/acn3.229","article-title":"Fine mapping of chromosome 15q25 implicates ZNF592 in neurosarcoidosis patients","volume":"2","author":"Lareau","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"2026020403042977500_bib52","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00415-014-7482-9","article-title":"Overview of neurosarcoidosis: recent advances","volume":"262","author":"Hebel","year":"2015","journal-title":"J Neurol"},{"key":"2026020403042977500_bib53","doi-asserted-by":"crossref","first-page":"S08","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.S08.006","article-title":"7T brain MR imaging of neurosarcoidosis: preliminary observations [abstract]","volume":"78","author":"Gelfand","year":"2012","journal-title":"Neurology"},{"key":"2026020403042977500_bib54","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1183\/09031936.00002512","article-title":"Sarcoidosis-associated fatigue","volume":"40","author":"Drent","year":"2012","journal-title":"Eur Respir J"},{"key":"2026020403042977500_bib55","first-page":"525","article-title":"Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients","volume":"52","author":"Neville","year":"1983","journal-title":"Q J Med"},{"key":"2026020403042977500_bib56","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0002-9343(60)90009-7","article-title":"Course and prognosis of sarcoidosis","volume":"29","author":"Sones","year":"1960","journal-title":"Am J Med"},{"key":"2026020403042977500_bib57","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1749-6632.1986.tb18537.x","article-title":"Factors affecting outcome of sarcoidosis: influence of race, extrathoracic involvement, and initial radiologic lung lesions","volume":"465","author":"Israel","year":"1986","journal-title":"Ann N Y Acad Sci"},{"key":"2026020403042977500_bib58","doi-asserted-by":"crossref","first-page":"802","DOI":"10.5301\/EJO.2011.6417","article-title":"Visual outcome in ocular sarcoidosis: retrospective evaluation of risk factors","volume":"21","author":"Miserocchi","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"2026020403042977500_bib59","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1442-9071.2003.00666.x","article-title":"Visual loss in sarcoid-related uveitis","volume":"31","author":"Lobo","year":"2003","journal-title":"Clin Experiment Ophthalmol"},{"key":"2026020403042977500_bib60","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/00000478-199312000-00009","article-title":"Hepatic sarcoidosis: clinicopathologic features in 100 patients","volume":"17","author":"Devaney","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"2026020403042977500_bib61","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1586\/17474124.2015.958468","article-title":"Clinical presentation and protocol for management of hepatic sarcoidosis","volume":"9","author":"Modaresi Esfeh","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2026020403042977500_bib62","first-page":"275","article-title":"Features of sarcoidosis associated with chronic disease","volume":"31","author":"Baughman","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026020403042977500_bib63","first-page":"204","article-title":"Two year prognosis of sarcoidosis: the ACCESS experience","volume":"20","author":"Judson","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026020403042977500_bib64","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1164\/rccm.201410-1785OC","article-title":"Validation and important differences for the Sarcoidosis Assessment Tool: a new patient-reported outcome measure","volume":"191","author":"Judson","year":"2015","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/14\/Supplement_6\/S437\/66716157\/annalsats_14_supplement_6_s437.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/14\/Supplement_6\/S437\/66716157\/annalsats_14_supplement_6_s437.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:04:44Z","timestamp":1770192284000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/14\/Supplement_6\/S437\/8454160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":64,"journal-issue":{"issue":"Supplement_6","published-online":{"date-parts":[[2017,12,1]]},"published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201707-566ot","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12]]},"published":{"date-parts":[[2017,12,1]]}}}